Brinker Scott M

Janus Living CEO Scott Brinker bought 100,000 shares for $2,000,000 at $20.00; stock now $23.75 on day 3

CEO Brinker's purchase of 100,000 shares at $20.00 totaling $2,000,000.00 represents a substantial initial stake in Janus Living just 3 trading days after the company's recent listing. The post-transaction holding of 100,000 shares grew from zero, indicating this is an inaugural insider position for the CEO. Notably, 5 other insiders purchased shares within the same 14-day window, establishing a multi-insider cluster buy pattern that suggests broad-based internal acquisition activity in the newly public equity. The stock has already moved to $23.75, pricing above the CEO's entry point of $20.00 within the first trading days.

Brinker (CEO) bought 1,490 shares of DOC at $16.83 on 2025-08-04; stock now $16.90, down 26.9% from 52-week high.

CEO Scott M Brinker purchased 1,490 shares at $16.83, a modest $25,076.70 addition to his 211.9K-share position. The purchase occurred after three recent buys within the prior week (2025-07-28, 2025-07-31), suggesting repeated accumulation while the stock trades near its 52-week low of $16.77. However, Brinker's historical performance as a buyer provides limited confidence: his cross-ticker track record shows zero wins in 90-day holding periods, and his single measurable prior DOC purchase (2025-04-28) delivered a 90-day return of -0.4%. The stock has declined 7.2% over the past 30 days, trading 26.9% below its 52-week high, presenting a context of sustained weakness rather than a clear inflection point.

HealthPeak Properties CEO Scott M Brinker bought 2,930 shares at $17.06 on 2025-07-31, expanding holdings to 210,416 shares.

CEO Scott M Brinker purchased 2,930 shares at $17.06, a transaction worth $49,985.80. The purchase occurred near the 52-week low of $16.82 and represents only a 1.4% increase to his 210,416-share holdings. Notably, Brinker has executed three buys at HealthPeak within recent months (2025-04-28, 2025-05-09, and 2025-07-28), yet his same-ticker track record shows prior buys delivered -1.5% and -0.8% returns within 30 days, with his 90-day timing pattern at zero. Across all holdings and tickers, his historical buys averaged -1.1% 30-day return and -0.4% 90-day return with a 0.00% win rate, suggesting consistent poor timing despite repeated acquisitions. The stock trades at a P/E of 70.58 with -26.7% decline from its 52-week high, yet the insider's purchasing pattern shows no historical ability to identify attractive entry points.

CEO Brinker buys 2,873 shares of HEALTHPEAK (DOC) at $17.40; stock down -24.9% from 52-week high.

CEO Scott M. Brinker purchased 2,873 shares at $17.40 on 2025-07-28, increasing his holdings from 204.6K to 207.5K shares. The stock currently trades at $17.37, near the lower end of its 52-week range ($16.82–$23.12) and down -24.9% from its 52-week high, suggesting a depressed entry point. However, Brinker's prior trades at DOC (two previous purchases on 2025-04-28 and 2025-05-09) show a pattern of negative returns: the April buy posted -0.4% over 90 days, while the May buy remains unresolved. Across his open-market history spanning multiple tickers, his 90-day win rate stands at 0.00%, indicating his purchase timing has not consistently preceded stock appreciation. The $50.0K purchase represents a modest 1.4% increase to his existing position in a company with a P/E of 72.38 and strong revenue growth of +23.8% annually, but without clear evidence of improved timing discipline.

CEO Brinker Scott M buys 2,750 shares of Healthpeak Properties at $17.39; joins 6 other insiders in cluster buy pattern.

Scott M. Brinker, President and CEO of Healthpeak Properties, purchased 2,750 shares at $17.39 on 2025-05-09, expanding his holdings to 204,613 shares. This purchase occurs within a cluster buy pattern, with 6 other insiders also buying within the past 14 days, suggesting coordinated or synchronized conviction among the leadership team. The stock currently trades at $17.55, only 0.9% above the transaction price, but is -24.1% from its 52-week high of $23.12 and down -10.5% over the past 90 days, indicating recent weakness. The company's fundamentals appear sound—annual revenue growth of +23.8%, net income of $42,828,000.00 on quarterly revenue of $702,889,000.00—though the elevated P/E of 43.88 reflects high market expectations relative to earnings. The synchronized buying by multiple executives during a period of stock underperformance relative to its 52-week range warrants monitoring to assess whether leadership's capital deployment signals underlying confidence in valuation or near-term recovery prospects.

CEO Scott M Brinker purchased 11,337 shares of DOC at $17.68; 4 other insiders also bought within 14 days (cluster pattern).

Scott M Brinker, President and CEO, acquired 11,337 shares at $17.68 on 2025-04-28 for $200,438.16, expanding his holdings to 201,863 shares (+6.0% vs pre-transaction holdings). This transaction occurs amid a notable cluster: 4 other insiders also bought within the past 14 days. The stock has declined significantly from its 52-week high of $23.12 (down 23.2%) and is down 12.1% over the past 30 days and 14.1% over 90 days, suggesting the CEO's purchase follows material recent weakness. The company fundamentals remain solid with annual revenue growth of +23.8%, though the elevated P/E of 44.38 reflects market pricing expectations. The convergence of multiple insider purchases during a period of price weakness and the CEO's own accumulation merits attention as a data point in assessing current valuation and management perspective.